How do peri-implant biologic parameters correspond with implant survival and peri-implantitis? A critical review

The aim of this critical review was to evaluate whether commonly used biologic diagnostic parameters correspond to implant survival and peri-implantitis prevalence.

Publications from 2011 to 2017 were selected by an electronic search using the Pubmed database of the US National Library of Medicine. Prospective and retrospective studies with a mean follow-up time of at least 5 years and reporting prevalence of peri-implantitis as well as mean bone loss and standard deviation were selected. The correlation between reported prevalence of peri-implantitis and reported implant survival, mean follow-up time, mean bone loss, mean probing depth, and mean bleeding on probing was calculated. Mean bone loss and standard deviation were used for estimation of proportion of implants with bone loss exceeding 1, 2, and 3 mm.

Full-text analysis was performed for 255 papers from 4,173 available ones, and 41 met all the inclusion criteria. The overall mean weighted survival rate was 96.9% (89.9%-100%) and the reported prevalence of peri-implantitis ranged between 0% and 39.7%, based on 15 different case definitions. The overall weighted bone loss was 1.1 mm based on 8,182 implants and an average mean loading time ranging from 5 to 20 years. No correlation was found between mean bone loss and the reported prevalence of peri-implantitis. The estimated prevalence of implants with bone loss above 2 mm was 23%. The overall weighted mean probing depth was 3.3 mm, and mean weighted bleeding was 52.2%. Only a weak correlation was found between survival and function time (r = -0.49). There was no relation between the probing depth or bleeding and the mean bone loss, mean follow-up time, and reported prevalence of peri-implantitis.

Biologic parameters mean probing depth and mean bleeding on probing do not correlate with mean bone loss and this irrespective of follow-up. Case definition for peri-implantitis varied significantly between studies indicating that an unambiguous definition based on a specified threshold for bone loss is not agreed upon in the literature.